Press Releases Archives

Press Releases

Sarah Ashby Rejoins Psychemedics Corporation as Vice President, General Counsel

March 22, 2021

Blog Posts, Corporate, News, Press Releases

ACTON, Mass., Dec. 17, 2020 (GLOBE NEWSWIRE) — Psychemedics Corporation (NASDAQ: PMD) announced that Sarah Ashby has rejoined the company as Vice President, General Counsel. In this important role, Sarah…

Andrew Limbek Joins Psychemedics Corporation as Vice President, Controller

March 22, 2021

admin

Blog Posts, Corporate, News, Press Releases

ACTON, Mass., Jan. 26, 2021 (GLOBE NEWSWIRE) — Psychemedics Corporation (NASDAQ: PMD) announced that Andrew Limbek had joined the Company as Vice President, Controller. In this important role, Andrew will…

Robyn C. Davis Joins Psychemedics Board of Directors

March 22, 2021

admin

Blog Posts, Corporate, News, Press Releases

ACTON, Mass., March 17, 2021 (GLOBE NEWSWIRE) — Psychemedics Corporation (NASDAQ: PMD) announced that Robyn C. Davis was unanimously elected to serve on the Board of Directors of Psychemedics Corporation…

Psychemedics Announces a “Vaping Panel” to Detect and Deter the use of Marijuana, CBD and Nicotine

May 8, 2020

admin

Blog Posts, Press Releases

A New and Cost-Effective Tool to Combat the E-cigarette Epidemic Among Youth ACTON, MA, May 5, 2020 (GLOBE NEWSWIRE) — Psychemedics Corporation (NASDAQ: PMD), the world leader and pioneer in…

Psychemedics Test for Cotinine (metabolite of Nicotine) Detection Cleared by FDA

April 29, 2020

admin

Blog Posts, Press Releases

A New and Cost-Effective Tool to Detect and Deter Nicotine use ACTON, MA, April 29, 2020 (GLOBE NEWSWIRE) — Psychemedics Corporation (NASDAQ: PMD), the world leader and pioneer in detecting…

Psychemedics Test for Fentanyl Detection Cleared by FDA

April 25, 2019

Psychemedics

Blog Posts, Press Releases

Industry’s first and only FDA-cleared Fentanyl screen available now ACTON, MA, April 24, 2019 (GLOBE NEWSWIRE) — Psychemedics Corporation (NASDAQ:PMD), the world leader and pioneer in detecting drugs of abuse…

Psychemedics Announces First Quarter Results And Declares 91st Consecutive Quarterly Dividend

April 25, 2019

Psychemedics

Press Releases

Acton, MA, April 23, 2019 — Psychemedics Corporation (NASDAQ:PMD) today announced first-quarter financial results for the period ended March 31, 2019. The Company also announced a quarterly dividend of $0.18…

New Psychemedics Offering Further Enhances Cocaine Detection

March 27, 2019

admin

Press Releases

Industry’s first commercial application of hydroxycocaines for detection SAN ANTONIO, TX and ACTON, MA, March 27, 2019 (GLOBE NEWSWIRE) — Psychemedics Corporation (NASDAQ: PMD), the world leader in detecting drugs…

Psychemedics Announces Addition of FDA-Cleared Benzodiazepines Hair Test

September 26, 2017

Psychemedics

Press Releases

In another first, the world’s largest hair drug testing company & scientific leader launches new test for Benzodiazepines Acton, Massachusetts, September 26, 2017 – Psychemedics Corporation (NASDAQ:PMD), hair testing pioneer…

Psychemedics Corporation Launches Synthetic Cannabinoids Hair Test

August 22, 2017

Psychemedics

Press Releases, Uncategorized

World’s largest hair drug testing company & scientific leader launches new tool for combatting rising Synthetic Cannabinoids (K2, Spice) abuse Acton, Massachusetts, August 22, 2017– Psychemedics Corporation (NASDAQ:PMD), hair testing…

Press Releases

Sarah Ashby Rejoins Psychemedics Corporation as Vice President, General Counsel

Andrew Limbek Joins Psychemedics Corporation as Vice President, Controller

Robyn C. Davis Joins Psychemedics Board of Directors

Psychemedics Announces a “Vaping Panel” to Detect and Deter the use of Marijuana, CBD and Nicotine

Psychemedics Test for Cotinine (metabolite of Nicotine) Detection Cleared by FDA

Psychemedics Test for Fentanyl Detection Cleared by FDA

Psychemedics Announces First Quarter Results And Declares 91st Consecutive Quarterly Dividend

New Psychemedics Offering Further Enhances Cocaine Detection

Psychemedics Announces Addition of FDA-Cleared Benzodiazepines Hair Test

Psychemedics Corporation Launches Synthetic Cannabinoids Hair Test

Recent Posts

Categories

Archives